Patient-reported outcomes with durvalumab, with or without tremelimumab, plus chemotherapy as first-line treatment for metastatic non-small-cell lung cancer (POSEIDON)
Titel:
Patient-reported outcomes with durvalumab, with or without tremelimumab, plus chemotherapy as first-line treatment for metastatic non-small-cell lung cancer (POSEIDON)
Auteur:
Garon, Edward B. Cho, Byoung Chul Luft, Alexander Alatorre-Alexander, Jorge Geater, Sarayut Lucien Kim, Sang-We Ursol, Grygorii Hussein, Maen Lim, Farah Louise Yang, Cheng-Ta Araujo, Luiz Henrique Saito, Haruhiro Reinmuth, Niels Medic, Nenad Mann, Helen Shi, Xiaojin Peters, Solange Mok, Tony Johnson, Melissa